<?xml version="1.0" encoding="UTF-8"?>
<document id="29662198">
	<sentence id="s1" text="Tumor-initiating cells (TIC) represent a subset of tumor cells with increased self-renewal capability.">
		<entity id="s1.e1" charOffset="24-27"
			type="GENE" text="TIC" ontology_id="23550"/>
		<entity id="s1.e2" charOffset="51-56"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="TICs display resistance to frontline cancer treatment and retain the ability to repopulate a tumor after therapy, leading to cancer relapse.">
		<entity id="s2.e1" charOffset="0-3"
			type="GENE" text="TIC" ontology_id="23550"/>
		<entity id="s2.e2" charOffset="37-43"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s2.e3" charOffset="93-98"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e3" pgr="false"/>
		<pair id="s2.p2" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="NOTCH signaling has been identified as an important driver of the TIC population, yet mechanisms governing regulation of this pathway in cancer remain to be fully elucidated.">
		<entity id="s3.e1" charOffset="66-69"
			type="GENE" text="TIC" ontology_id="23550"/>
		<entity id="s3.e2" charOffset="137-143"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Here we identify a novel mechanism of NOTCH regulation and TIC induction in breast cancer via the miR-106b-25 miRNA cluster.">
		<entity id="s4.e1" charOffset="59-62"
			type="GENE" text="TIC" ontology_id="23550"/>
		<entity id="s4.e2" charOffset="83-89"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s4.e3" charOffset="98-101"
			type="GENE" text="miR" ontology_id="220972"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
		<pair id="s4.p2" e1="s4.e2"
		    e2="s4.e3" pgr="false"/>
	</sentence>
	<sentence id="s5" text="We show that the miR-106b-25 cluster upregulates NOTCH1 in multiple breast cancer cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L.">
		<entity id="s5.e1" charOffset="17-20"
			type="GENE" text="miR" ontology_id="220972"/>
		<entity id="s5.e2" charOffset="49-55"
			type="GENE" text="NOTCH1" ontology_id="4851"/>
		<entity id="s5.e3" charOffset="75-81"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s5.e4" charOffset="231-237"
			type="GENE" text="NEDD4L" ontology_id="23327"/>
		<pair id="s5.p1" e1="s5.e1"
		    e2="s5.e3" pgr="false"/>
		<pair id="s5.p2" e1="s5.e2"
		    e2="s5.e3" pgr="true"/>
		<pair id="s5.p3" e1="s5.e3"
		    e2="s5.e4" pgr="false"/>
	</sentence>
	<sentence id="s6" text="We further show that upregulation of NOTCH1 is necessary for TIC induction downstream of miR-106b-25 in both ER + and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.">
		<entity id="s6.e1" charOffset="37-43"
			type="GENE" text="NOTCH1" ontology_id="4851"/>
		<entity id="s6.e2" charOffset="61-64"
			type="GENE" text="TIC" ontology_id="23550"/>
		<entity id="s6.e3" charOffset="89-92"
			type="GENE" text="miR" ontology_id="220972"/>
		<entity id="s6.e4" charOffset="130-136"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s6.e5" charOffset="170-176"
			type="GENE" text="NEDD4L" ontology_id="23327"/>
		<pair id="s6.p1" e1="s6.e4"
		    e2="s6.e4" pgr="false"/>
		<pair id="s6.p2" e1="s6.e3"
		    e2="s6.e4" pgr="false"/>
		<pair id="s6.p3" e1="s6.e1"
		    e2="s6.e4" pgr="true"/>
		<pair id="s6.p4" e1="s6.e4"
		    e2="s6.e5" pgr="false"/>
	</sentence>
	<sentence id="s7" text="Importantly, we demonstrate a significant positive correlation between miR-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and NEDD4L mRNA in human breast cancer, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.">
		<entity id="s7.e1" charOffset="71-74"
			type="GENE" text="miR" ontology_id="220972"/>
		<entity id="s7.e2" charOffset="87-93"
			type="GENE" text="NOTCH1" ontology_id="4851"/>
		<entity id="s7.e3" charOffset="165-171"
			type="GENE" text="NEDD4L" ontology_id="23327"/>
		<entity id="s7.e4" charOffset="193-199"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s7.p1" e1="s7.e1"
		    e2="s7.e4" pgr="false"/>
		<pair id="s7.p2" e1="s7.e2"
		    e2="s7.e4" pgr="true"/>
		<pair id="s7.p3" e1="s7.e3"
		    e2="s7.e4" pgr="false"/>
	</sentence>
	<sentence id="s8" text="Further, we show for the first time that NEDD4L expression alone is significantly associated with a better relapse-free prognosis for breast cancer patients.">
		<entity id="s8.e1" charOffset="41-47"
			type="GENE" text="NEDD4L" ontology_id="23327"/>
		<entity id="s8.e2" charOffset="141-147"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s8.p1" e1="s8.e1"
		    e2="s8.e2" pgr="false"/>
	</sentence>
	<sentence id="s9" text="These data expand our knowledge of the mechanisms underlying NOTCH activation and TIC induction in breast cancer, and may provide new avenues for the development of therapies targeting this resistant subset of tumor cells">
		<entity id="s9.e1" charOffset="82-85"
			type="GENE" text="TIC" ontology_id="23550"/>
		<entity id="s9.e2" charOffset="106-112"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s9.e3" charOffset="210-215"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s9.p1" e1="s9.e1"
		    e2="s9.e3" pgr="false"/>
		<pair id="s9.p2" e1="s9.e1"
		    e2="s9.e2" pgr="false"/>
	</sentence>
</document>
